157 related articles for article (PubMed ID: 3867114)
1. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
Hafter R; Schröck R; von Hugo R; Graeff H
Scand J Clin Lab Invest Suppl; 1985; 178():137-44. PubMed ID: 3867114
[TBL] [Abstract][Full Text] [Related]
2. [A test for the detection of fibrin in the plasma].
Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
[TBL] [Abstract][Full Text] [Related]
3. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
4. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
Graeff H; Klaubert W; Klaubert E; Gollwitzer R; von Hugo R; Hafter R
Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():42-6. PubMed ID: 6555132
[TBL] [Abstract][Full Text] [Related]
5. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
6. Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis.
Rowbotham BJ; Carroll P; Whitaker AN; Bunce IH; Cobcroft RG; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ
Thromb Haemost; 1987 Feb; 57(1):59-61. PubMed ID: 3590082
[TBL] [Abstract][Full Text] [Related]
7. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
8. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
Declerck PJ; Mombaerts P; Holvoet P; De Mol M; Collen D
Thromb Haemost; 1987 Dec; 58(4):1024-9. PubMed ID: 3127914
[TBL] [Abstract][Full Text] [Related]
10. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
[TBL] [Abstract][Full Text] [Related]
11. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
Trofatter KF; Howell ML; Greenberg CS; Hage ML
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
Barsotti A; Savarino A
Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
[TBL] [Abstract][Full Text] [Related]
13. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.
Dempfle CE; Zips S; Ergül H; Heene DL;
Thromb Haemost; 2001 Apr; 85(4):671-8. PubMed ID: 11341504
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.
Jansen FH; van der Straaten HM; Roest M; Haas F; de Groot PG; Fijnheer R
Haematologica; 2005 Apr; 90(4):499-504. PubMed ID: 15820946
[TBL] [Abstract][Full Text] [Related]
17. [Plasma D-dimer levels in patients with deep vein thrombosis].
Watanabe R; Wada H; Mori Y; Nakasaki T; Sawa H; Shiku H
Rinsho Byori; 1999 Sep; 47(9):887-90. PubMed ID: 10518428
[TBL] [Abstract][Full Text] [Related]
18. Plasma D dimer: a useful marker of fibrin breakdown in renal failure.
Gordge MP; Faint RW; Rylance PB; Ireland H; Lane DA; Neild GH
Thromb Haemost; 1989 Jun; 61(3):522-5. PubMed ID: 2799764
[TBL] [Abstract][Full Text] [Related]
19. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
[TBL] [Abstract][Full Text] [Related]
20. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
